AAV8.CMV.hPEX1.HA

N/A

Report date: 2024/12/20 13:56:51

Base Information

Drug NameAAV8.CMV.hPEX1.HA
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionPeroxisomal ATPase PEX1 gene transference
TargetsPeroxisomal ATPase PEX1
Therapy Area/IndicationsZellweger Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMcGill University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMcGill University
Active IndicationsN/A
Inactive IndicationsZellweger Syndrome

Other Information

ATC CodeN/A
Related LinksN/A